10-Q Filing

INTUITIVE SURGICAL INC CIK: 1035267 Q3 2020

Filing Information

Form Type	10-Q
Accession Number	`0001035267-20-000166`
Period End Date	20200930
Filing Date	20201019
Fiscal Year	2020
Fiscal Period	Q3
XBRL Instance	isrg-20200930_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 82 Income Statement 72 Cash Flow Statement 70

Balance Sheet 82 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	2.50M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	2.50M	shares	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.17B	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.37B	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Short-term investments	`MarketableSecuritiesCurrent`	$3.35B	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Short-term investments	`MarketableSecuritiesCurrent`	$2.05B	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$588.60M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$645.20M	USD	Point-in-time
Inventory	`InventoryNet`	$595.50M	USD	Point-in-time
Inventory	`InventoryNet`	$662.90M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	116.00M	shares	Point-in-time
Prepaids and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$330.60M	USD	Point-in-time
Prepaids and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$200.20M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	117.50M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$4.66B	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	117.50M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	116.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$6.30B	USD	Point-in-time
Property, plant, and equipment, net	`PropertyPlantAndEquipmentNet`	$1.27B	USD	Point-in-time
Property, plant, and equipment, net	`PropertyPlantAndEquipmentNet`	$1.51B	USD	Point-in-time
Long-term investments	`MarketableSecuritiesNoncurrent`	$1.64B	USD	Point-in-time
Long-term investments	`MarketableSecuritiesNoncurrent`	$2.62B	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	$425.60M	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	$360.30M	USD	Point-in-time
Intangible and other assets, net	`IntangibleAndOtherAssets`	$467.70M	USD	Point-in-time
Intangible and other assets, net	`IntangibleAndOtherAssets`	$441.40M	USD	Point-in-time
Goodwill	`Goodwill`	$336.30M	USD	Point-in-time
Goodwill	`Goodwill`	$307.20M	USD	Point-in-time
Total assets	`Assets`	$10.62B	USD	Point-in-time
Total assets	`Assets`	$9.73B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$123.50M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$116.00M	USD	Point-in-time
Accrued compensation and employee benefits	`EmployeeRelatedLiabilitiesCurrent`	$251.60M	USD	Point-in-time
Accrued compensation and employee benefits	`EmployeeRelatedLiabilitiesCurrent`	$175.20M	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$327.80M	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$337.80M	USD	Point-in-time
Other accrued liabilities	`OtherLiabilitiesCurrent`	$275.70M	USD	Point-in-time
Other accrued liabilities	`OtherLiabilitiesCurrent`	$317.30M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.03B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$894.70M	USD	Point-in-time
Other long-term liabilities	`LiabilitiesOtherThanLongtermDebtNoncurrent`	$436.10M	USD	Point-in-time
Other long-term liabilities	`LiabilitiesOtherThanLongtermDebtNoncurrent`	$418.30M	USD	Point-in-time
Total liabilities	`Liabilities`	$1.33B	USD	Point-in-time
Total liabilities	`Liabilities`	$1.45B	USD	Point-in-time
Contingencies (Note 8)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Contingencies (Note 8)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, 2.5 shares authorized, $0.001 par value, issuable in series; no shares issued and outstanding as of June 30, 2020, and December 31, 2019	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, 2.5 shares authorized, $0.001 par value, issuable in series; no shares issued and outstanding as of June 30, 2020, and December 31, 2019	`PreferredStockValue`	-	USD	Point-in-time
Common stock, 300.0 shares authorized, $0.001 par value, 117.0 shares and 116.0 shares issued and outstanding as of June 30, 2020, and December 31, 2019, respectively	`CommonStockValue`	$100.00K	USD	Point-in-time
Common stock, 300.0 shares authorized, $0.001 par value, 117.0 shares and 116.0 shares issued and outstanding as of June 30, 2020, and December 31, 2019, respectively	`CommonStockValue`	$100.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$5.76B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$6.30B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$2.49B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$2.94B	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$17.80M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-13.30M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$22.30M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$12.40M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$16.10M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$16.20M	USD	Point-in-time
Total Intuitive Surgical, Inc. stockholders equity	`StockholdersEquity`	$9.26B	USD	Point-in-time
Total Intuitive Surgical, Inc. stockholders equity	`StockholdersEquity`	$8.26B	USD	Point-in-time
Noncontrolling interest in joint venture	`MinorityInterest`	$28.90M	USD	Point-in-time
Noncontrolling interest in joint venture	`MinorityInterest`	$20.90M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.28B	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.77B	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$7.28B	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$7.78B	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$9.29B	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.69B	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$10.62B	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$9.73B	USD	Point-in-time

Income Statement 72 line items

Line Item	Tag	Value	Unit	Period
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.08B	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.13B	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$3.20B	USD	3 Qtrs
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$3.03B	USD	3 Qtrs
Total cost of revenue	`CostOfGoodsAndServicesSold`	$353.40M	USD	1 Quarter
Total cost of revenue	`CostOfGoodsAndServicesSold`	$342.60M	USD	1 Quarter
Total cost of revenue	`CostOfGoodsAndServicesSold`	$986.60M	USD	3 Qtrs
Total cost of revenue	`CostOfGoodsAndServicesSold`	$1.06B	USD	3 Qtrs
Gross profit	`GrossProfit`	$1.97B	USD	3 Qtrs
Gross profit	`GrossProfit`	$785.60M	USD	1 Quarter
Gross profit	`GrossProfit`	$724.30M	USD	1 Quarter
Gross profit	`GrossProfit`	$2.21B	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$886.10M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$836.60M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$284.00M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$298.90M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$155.00M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$135.90M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$445.30M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$400.70M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$419.90M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$1.33B	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$1.24B	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$453.90M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$634.00M	USD	3 Qtrs
Income from operations	`OperatingIncomeLoss`	$270.40M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$365.70M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$976.90M	USD	3 Qtrs
Interest and other income, net	`NonoperatingIncomeExpense`	$84.80M	USD	1 Quarter
Interest and other income, net	`NonoperatingIncomeExpense`	$136.50M	USD	3 Qtrs
Interest and other income, net	`NonoperatingIncomeExpense`	$93.60M	USD	3 Qtrs
Interest and other income, net	`NonoperatingIncomeExpense`	$33.30M	USD	1 Quarter
Income before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$1.07B	USD	3 Qtrs
Income before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$399.00M	USD	1 Quarter
Income before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$355.20M	USD	1 Quarter
Income before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$770.50M	USD	3 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$51.40M	USD	3 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$67.30M	USD	3 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$38.40M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$300.00K	USD	1 Quarter
Net income	`ProfitLoss`	$1.02B	USD	3 Qtrs
Net income	`ProfitLoss`	$398.70M	USD	1 Quarter
Net income	`ProfitLoss`	$316.80M	USD	1 Quarter
Net income	`ProfitLoss`	$703.20M	USD	3 Qtrs
Less: net loss attributable to noncontrolling interest in joint venture	`NetIncomeLossAttributableToNoncontrollingInterest`	$-2.50M	USD	3 Qtrs
Less: net loss attributable to noncontrolling interest in joint venture	`NetIncomeLossAttributableToNoncontrollingInterest`	$2.90M	USD	1 Quarter
Less: net loss attributable to noncontrolling interest in joint venture	`NetIncomeLossAttributableToNoncontrollingInterest`	$7.80M	USD	3 Qtrs
Less: net loss attributable to noncontrolling interest in joint venture	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.90M	USD	1 Quarter
Net income attributable to Intuitive Surgical, Inc.	`NetIncomeLoss`	$695.40M	USD	3 Qtrs
Net income attributable to Intuitive Surgical, Inc.	`NetIncomeLoss`	$396.80M	USD	1 Quarter
Net income attributable to Intuitive Surgical, Inc.	`NetIncomeLoss`	$313.90M	USD	1 Quarter
Net income attributable to Intuitive Surgical, Inc.	`NetIncomeLoss`	$1.02B	USD	3 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$8.86	USD	3 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$2.68	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$5.95	USD	3 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$3.44	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$5.80	USD	3 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$8.56	USD	3 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$3.33	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$2.60	USD	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	115.30M	shares	3 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	115.40M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	116.80M	shares	3 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	117.30M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	119.30M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	120.60M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	119.40M	shares	3 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	120.00M	shares	3 Qtrs
Total comprehensive income attributable to Intuitive Surgical, Inc.	`ComprehensiveIncomeNetOfTax`	$398.50M	USD	1 Quarter
Total comprehensive income attributable to Intuitive Surgical, Inc.	`ComprehensiveIncomeNetOfTax`	$1.05B	USD	3 Qtrs
Total comprehensive income attributable to Intuitive Surgical, Inc.	`ComprehensiveIncomeNetOfTax`	$699.20M	USD	3 Qtrs
Total comprehensive income attributable to Intuitive Surgical, Inc.	`ComprehensiveIncomeNetOfTax`	$307.80M	USD	1 Quarter

Cash Flow Statement 70 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$316.80M	USD	1 Quarter
Net income	`ProfitLoss`	$703.20M	USD	3 Qtrs
Net income	`ProfitLoss`	$1.02B	USD	3 Qtrs
Net income	`ProfitLoss`	$398.70M	USD	1 Quarter
Depreciation and loss on disposal of property, plant, and equipment	`Depreciation`	$159.10M	USD	3 Qtrs
Depreciation and loss on disposal of property, plant, and equipment	`Depreciation`	$108.00M	USD	3 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$37.30M	USD	3 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$10.70M	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$31.20M	USD	3 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$12.60M	USD	1 Quarter
Loss (gain) on investments, accretion, and amortization, net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$64.20M	USD	3 Qtrs
Loss (gain) on investments, accretion, and amortization, net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$6.60M	USD	3 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-8.30M	USD	3 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$71.90M	USD	3 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$292.30M	USD	3 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$246.60M	USD	3 Qtrs
Amortization of contract acquisition assets	`CapitalizedContractCostAmortization`	$12.40M	USD	3 Qtrs
Amortization of contract acquisition assets	`CapitalizedContractCostAmortization`	$9.20M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-57.20M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-50.60M	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$177.00M	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$293.40M	USD	3 Qtrs
Prepaids and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$118.80M	USD	3 Qtrs
Prepaids and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$95.10M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$24.70M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-3.90M	USD	3 Qtrs
Accrued compensation and employee benefits	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-76.40M	USD	3 Qtrs
Accrued compensation and employee benefits	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-6.80M	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-9.20M	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$5.80M	USD	3 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-39.50M	USD	3 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-26.60M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$857.30M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$1.05B	USD	3 Qtrs
Purchase of investments	`PaymentsToAcquireMarketableSecurities`	$2.54B	USD	3 Qtrs
Purchase of investments	`PaymentsToAcquireMarketableSecurities`	$3.02B	USD	3 Qtrs
Proceeds from Sale of Investments	`ProceedsFromSaleOfAvailableForSaleSecurities`	$82.10M	USD	3 Qtrs
Proceeds from Sale of Investments	`ProceedsFromSaleOfAvailableForSaleSecurities`	$800.70M	USD	3 Qtrs
Proceeds from maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$2.03B	USD	3 Qtrs
Proceeds from maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$1.93B	USD	3 Qtrs
Purchase of property, plant, and equipment and intellectual property	`PaymentsToAcquireProductiveAssets`	$279.60M	USD	3 Qtrs
Purchase of property, plant, and equipment and intellectual property	`PaymentsToAcquireProductiveAssets`	$283.60M	USD	3 Qtrs
Acquisition of businesses, net of cash	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$31.80M	USD	3 Qtrs
Acquisition of businesses, net of cash	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$37.70M	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-606.30M	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-748.20M	USD	3 Qtrs
Proceeds from issuance of common stock relating to employee stock plans	`ProceedsFromStockPlans`	$205.70M	USD	3 Qtrs
Proceeds from issuance of common stock relating to employee stock plans	`ProceedsFromStockPlans`	$267.90M	USD	3 Qtrs
Taxes paid related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$165.30M	USD	3 Qtrs
Taxes paid related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$152.90M	USD	3 Qtrs
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	$269.50M	USD	3 Qtrs
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	$100.00M	USD	3 Qtrs
Capital contribution from noncontrolling interest	`ProceedsFromMinorityShareholders`	$10.00M	USD	3 Qtrs
Capital contribution from noncontrolling interest	`ProceedsFromMinorityShareholders`	-	USD	3 Qtrs
Payment of deferred purchase consideration	`ProceedsFromPaymentsForOtherFinancingActivities`	$-48.50M	USD	3 Qtrs
Payment of deferred purchase consideration	`ProceedsFromPaymentsForOtherFinancingActivities`	$-12.50M	USD	3 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-45.90M	USD	3 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-219.20M	USD	3 Qtrs
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-2.90M	USD	3 Qtrs
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-2.00M	USD	3 Qtrs
Net increase (decrease) in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$203.10M	USD	3 Qtrs
Net increase (decrease) in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$75.20M	USD	3 Qtrs
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$984.60M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$909.40M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.39B	USD	Point-in-time
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.18B	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$984.60M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$909.40M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.39B	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.18B	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.